Pancreatic Cancer Research

ResearcherMichael E. DeBakey VA Medical CenterActive in the last 2 years

Hashem B. El‐Serag

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5964-7579; OpenAlex author ID A5027343826. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2018: 3 papers · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 10

  1. Defining and Understanding Diagnostic Delays Among Pancreatic Cancer Patients: A Retrospective Cohort Study. Co-author DOI 10.1016/j.cgh.2024.07.006↗
  2. Emergency Presentations Predict Worse Outcomes Among Patients with Pancreatic Cancer. Co-author DOI 10.1007/s10620-023-08207-6↗
  3. The Impact of Race on Pancreatic Cancer Treatment and Survival in the Nationwide Veterans Affairs Healthcare System. Co-author DOI 10.1097/mpa.0000000000002272↗
  4. Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System. Co-author DOI 10.1007/s10620-023-08035-8↗
  5. Burden of Pancreatic Cancer: From Epidemiology to Practice. First author DOI 10.1016/j.cgh.2020.02.054↗
  6. The Influence of Gut and Tumor Microbiome on Pancreatic Cancer Outcomes. First author DOI 10.1053/j.gastro.2020.07.008↗
  7. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Co-author DOI 10.1158/1940-6207.capr-18-0201↗
  8. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Co-author DOI 10.1002/cam4.1426↗
  9. Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Last author DOI 10.1093/jnci/djx117↗
  10. Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women's Health Initiative Study. Co-author DOI 10.3390/jcm7080197↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Natalia I. Khalaf · 6 shared papers, 2020–2025 · strength 1.33
  2. Fasiha Kanwal · 5 shared papers, 2020–2025 · strength 1.14
  3. Hardeep Singh · 4 shared papers, 2023–2025 · strength 0.98
  4. Yan Liu · 2 shared papers, 2023–2024 · strength 0.43
  5. Li Jiao · 4 shared papers, 2018–2019 · strength 0.32
  6. Basim Ali · 1 shared paper, 2024 · strength 0.24
  7. Donna L. White · 3 shared papers, 2018 · strength 0.23
  8. Aaron P. Thrift · 1 shared paper, 2021 · strength 0.19
  9. Johanna L. Chan · 1 shared paper, 2020 · strength 0.16
  10. Subrata Sen · 1 shared paper, 2019 · strength 0.08
  11. Nagireddy Putluri · 1 shared paper, 2019 · strength 0.08
  12. Zhensheng Wang · 1 shared paper, 2018 · strength 0.08
  13. Thomas E. Rohan · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.